How does prescribing for antihypertensive products stack up against guideline recommendations? An Australian population-based study (2006-2014).

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27302475)

Published in Br J Clin Pharmacol on July 28, 2016

Authors

Andrea L Schaffer1, Sallie-Anne Pearson2, Nicholas A Buckley3

Author Affiliations

1: Centre for Big Data Research in Health, University of New South Wales, Sydney, NSW, 2052, Australia. andrea.schaffer@student.unsw.edu.au.
2: Centre for Big Data Research in Health, University of New South Wales, Sydney, NSW, 2052, Australia.
3: Blackburn Building (D06), University of Sydney, Sydney, NSW, 2006, Australia.

Articles cited by this

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28

2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA (2014) 34.12

Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens (2009) 3.70

Interventions for enhancing medication adherence. Cochrane Database Syst Rev (2014) 2.82

Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension (2009) 2.28

An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. Hypertension (2013) 1.95

Meta-analysis: impact of drug class on adherence to antihypertensives. Circulation (2011) 1.81

The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol (2015) 1.66

Initial combination therapy reduces the risk of cardiovascular events in hypertensive patients: a matched cohort study. Hypertension (2012) 1.65

Antihypertensive medication use among US adults with hypertension. Circulation (2006) 1.64

Antihypertensive medication classes used among medicare beneficiaries initiating treatment in 2007-2010. PLoS One (2014) 1.45

Evaluating the costs and benefits of using combination therapies. Med J Aust (2014) 1.43

Single-pill vs free-equivalent combination therapies for hypertension: a meta-analysis of health care costs and adherence. J Clin Hypertens (Greenwich) (2011) 1.34

Initial monotherapy and combination therapy and hypertension control the first year. Hypertension (2012) 1.15

Adherence and persistence of single-pill ARB/CCB combination therapy compared to multiple-pill ARB/CCB regimens. Curr Med Res Opin (2010) 1.00

Reduced discontinuation of antihypertensive treatment by two-drug combination as first step. Evidence from daily life practice. J Hypertens (2010) 0.99

Assessment of adherence, persistence, and costs among valsartan and hydrochlorothiazide retrospective cohorts in free-and fixed-dose combinations. Curr Med Res Opin (2008) 0.98

Persistence with antihypertensive treatments: results of a 3-year follow-up cohort study. Eur J Clin Pharmacol (2007) 0.96

Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy. J Med Econ (2011) 0.92

Combination therapy as initial treatment for newly diagnosed hypertension. Am Heart J (2011) 0.88

Economic impact of switching to fixed-dose combination therapy for Japanese hypertensive patients: a retrospective cost analysis. BMC Health Serv Res (2013) 0.86

Evaluation of compliance and health care utilization in patients treated with single pill vs. free combination antihypertensives. Curr Med Res Opin (2010) 0.85

Antihypertensive drug prescribing and persistence among new elderly users: implications for persistence improvement interventions. Can J Cardiol (2014) 0.85

First-fill medication discontinuations and nonadherence to antihypertensive therapy: an observational study. Am J Hypertens (2011) 0.84

Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy. BMC Fam Pract (2008) 0.83

Persistence with a single pill versus two pills of amlodipine and atorvastatin: the Australian experience, 2006-2010. Med J Aust (2011) 0.83

National utilization of antihypertensive medications from 2000 to 2006 in the Veterans Health Administration: focus on thiazide diuretics. J Clin Hypertens (Greenwich) (2008) 0.82

Low-dose combination therapy: an important first-line treatment in the management of hypertension. Am J Hypertens (2001) 0.81

Antihypertensive Combination Treatment: State of the Art. Curr Hypertens Rep (2015) 0.81

Fixed-dose combination therapy in hypertension: cons. High Blood Press Cardiovasc Prev (2012) 0.80

Rates and determinants of reinitiating antihypertensive therapy after prolonged stoppage: a population-based study. J Hypertens (2007) 0.80

Increasing complexity: which drug class to choose for treatment of hypertension in the elderly? Clin Interv Aging (2014) 0.79

Queen Mary Utilization of Antihypertensive Drugs Study: use of antihypertensive drug classes in the hypertension clinic 1996-2004. Br J Clin Pharmacol (2005) 0.79

Use of antihypertensive medications among United States veterans newly diagnosed with hypertension. Curr Med Res Opin (2008) 0.77

Combination therapy in hypertension: an Asia-Pacific consensus viewpoint. Curr Med Res Opin (2015) 0.77

Antihypertensive use before and after initiation of fixed-dose combination products in Australia: a retrospective study. Int J Clin Pharm (2013) 0.77